09:29 AM EDT, 08/22/2024 (MT Newswires) -- AtriCure ( ATRC ) said Thursday it has received an expanded indication in CE-marked countries in Europe for the AtriClip device.

The product can now be used in patients at "high risk" of thromboembolism for whom left atrial appendage exclusion is warranted, the company said.

The AtriClip devices are used during cardiac surgery to reduce the risk of stroke by isolating and excluding the left atrial appendage, a primary source of blood clots in atrial fibrillation patients.

Price: 23.98, Change: -0.01, Percent Change: -0.04